3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
202
Central Nervous System Neoplasms
122
Brain Neoplasms
107
Gliosarcoma
85
Glioma
68
Astrocytoma
63
Oligodendroglioma
34
Neuroblastoma
29
Medulloblastoma
20
Neoplasm Metastasis
19
Carcinoma, Non-Small-Cell Lung
15
Lung Neoplasms
14
Ependymoma
11
Diffuse Intrinsic Pontine Glioma
11
Breast Neoplasms
11
Meningeal Carcinomatosis
8
Neoplasms
7
Lymphoma
7
Squamous Cell Carcinoma of Head and Neck
6
Sarcoma
6
Optic Nerve Glioma
6
Neuroectodermal Tumors, Primitive
6
Lymphoma, Follicular
6
Head and Neck Neoplasms
6
Esthesioneuroblastoma, Olfactory
6
Burkitt Lymphoma
6
Spinal Cord Neoplasms
5
Salivary Gland Neoplasms
5
Rhabdoid Tumor
5
Recurrence
5
Interventions
ziprasidone
1
perampanel
1
clevidipine
1
brivaracetam
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Topotecan
1
Tobramycin
1
Temozolomide
1
Sulfasalazine
1
Spironolactone
1
Sevoflurane
1
Sevelamer
1
Saline Solution
1
Rocuronium
1
Radiotherapy
1
Propofol
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nitrous Oxide
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Memantine
1
Magnetoencephalography
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Epilepsy
×
Radiotherapy
×
CNS
×
Clear all
NCT05664464
2024-05-10
GLUGLIO
University of Zurich
Phase 1/2
Recruiting
120 enrolled